These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2853427)

  • 1. [Epidermodysplasia verruciformis caused by HPV 12 virus].
    Misiewicz J; Rubisz-Brzezińska J; Jabłońska S
    Przegl Dermatol; 1988; 75(4):286-92. PubMed ID: 2853427
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis.
    Yutsudo M; Tanigaki T; Kanda R; Sasagawa T; Inoue T; Jing P; Yong-Il H; Hakura A
    J Clin Microbiol; 1994 Apr; 32(4):1076-8. PubMed ID: 8027315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.
    Majewski S; Jabłońska S
    Arch Dermatol; 1995 Nov; 131(11):1312-8. PubMed ID: 7503577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel human papillomavirus identified in epidermodysplasia verruciformis.
    Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
    Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current aspects of diseases due to papillomaviruses].
    Jablonska S
    Bull Mem Acad R Med Belg; 1986; 141(11-12):530-40. PubMed ID: 3036287
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidermodysplasia verruciformis associated with intestinal lymphoma: a model of viral oncogenicity.
    Youssef M; Denguezli M; Ghariani N; Belajouza C; Nouira R
    Pediatr Dermatol; 2007; 24(5):511-3. PubMed ID: 17958799
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidermodysplasia verruciformis-like lesions in a patient with systemic lupus erythematosus.
    García-Río I; Garcia-F-Villalta MJ; Daudén E; Fraga J; García-Díez A
    Acta Derm Venereol; 2003; 83(3):229-30. PubMed ID: 12816165
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn.
    Carlson JA; Cribier B; Nuovo G; Rohwedder A
    J Am Acad Dermatol; 2008 Aug; 59(2):279-94. PubMed ID: 18638629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermodysplasia verruciform-like Lesions in an HIV patient.
    Berk DR; Bruckner AL; Lu D
    Dermatol Online J; 2009 Jan; 15(1):1. PubMed ID: 19281706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomaviruses and cancer.
    Lowy DR; Sedman SA; Cohen BD; Schiller JT
    Recent Results Cancer Res; 1993; 128():351-2. PubMed ID: 8395073
    [No Abstract]   [Full Text] [Related]  

  • 11. Human papillomaviruses and impaired immunity vs epidermodysplasia verruciformis.
    Pfister H
    Arch Dermatol; 1987 Nov; 123(11):1469-70. PubMed ID: 2823725
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidermodysplasia verruciformis in a young man with HIV since birth--case report.
    Meireles SI; Andrade SM; Lima CL; Pires MC
    An Bras Dermatol; 2013; 88(6 Suppl 1):190-2. PubMed ID: 24346916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunology of HPV infections and mechanism of a latent infection].
    Jabłńska S; Majewski S; Malejczyk J
    Hautarzt; 1992 May; 43(5):305-11. PubMed ID: 1319419
    [No Abstract]   [Full Text] [Related]  

  • 14. Cloning of mucosal and cutaneous HPV sequences in a metastatic squamous cell carcinoma from an epidermodysplasia verruciformis patient.
    Payne D; Chan TS; Wagner R; Tyring SK
    Anticancer Res; 1996; 16(3A):1165-6. PubMed ID: 8702229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion.
    Majewski S; Jablonska S
    Cancer Res; 1997 Oct; 57(19):4214-6. PubMed ID: 9331078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
    Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
    Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermodysplasia verruciformis in the setting of HIV infection.
    Chen P; Kamino H; Walters RF; Rosenman K; Pomeranz MK; Sanchez M
    Dermatol Online J; 2008 Oct; 14(10):1. PubMed ID: 19061600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermodysplasia verruciformis: immunological and clinical aspects.
    Jablonska S; Majewski S
    Curr Top Microbiol Immunol; 1994; 186():157-75. PubMed ID: 8205840
    [No Abstract]   [Full Text] [Related]  

  • 19. Perianal Epidermodysplasia Verruciformis Associated With Human Papillomavirus 5 After a Renal Transplant.
    Edwards L; Reutter JC; Foster TE; Rady PL; Tyring SK
    J Low Genit Tract Dis; 2017 Jul; 21(3):e35-e36. PubMed ID: 28504981
    [No Abstract]   [Full Text] [Related]  

  • 20. P53 expression and human papillomavirus infection in transplant recipients and in patients with epidermodysplasia verruciformis.
    McGregor JM; McKee PH; Khorshid M; Proby CM
    Br J Dermatol; 1996 Feb; 134(2):374. PubMed ID: 8746364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.